Citation Impact
Citing Papers
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
General methods for the analysis of metabolic profiles of bile acids and related compounds in feces.
1983
Bile acid transporters
2009
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Enzymatic measurement of choline-containing phospholipids in bile.
1981
The Long–Term Outcomes of Patients With Compensated Hepatitis C Virus-Related Cirrhosis and History of Parenteral Exposure in the United States
1999
Functional Bowel Disorders
2006 Standout
Kidney stones: pathophysiology and medical management
2006 Standout
Lipid flow in bile formation
1992
Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes
2000
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
1994 Standout
Hepatitis C Virus Infection
2001 Standout
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
1993 Standout
Accurate enzymatic measurement of fecal bile acids in patients with malabsorption
2003
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
The C. elegans Cell Corpse Engulfment Gene ced-7 Encodes a Protein Similar to ABC Transporters
1998 StandoutNobel
Dynamics of Alanine Aminotransferase During Hepatitis C Virus Treatment
2003
Specificity of receptor–ligand interactions and their effect on dimerisation as observed by electrospray mass spectrometry: bile acids form stable adducts to the RXRα
2005
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
INBORN ERRORS OF BILE ACID BIOSYNTHESIS AND TRANSPORT
1999
Current status of ablative therapies in esophageal disorders
2001
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea‐predominant irritable bowel syndrome
2009
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
2001 StandoutNature
Esophageal Cancer
2003 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: A cohort analysis
1999
Mechanisms and Management of Antibiotic‐Associated Diarrhea
1998
Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003
2004
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia
1999
The Pathogenesis and Treatment of Kidney Stones
1992
Obesity, Weight Gain, and the Risk of Kidney Stones
2005 Standout
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Mitochondrial control of cell death
2000 Standout
Treating viral hepatitis C: efficacy, side effects, and complications
2006
Antiviral therapy for chronic hepatitis C: past, present, and future
2006
Reduction of Health–Related Quality of Life in Chronic Hepatitis C and Improvement With Interferon Therapy
1999
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
2002
Idiopathic bile acid malabsorption: qualitative and quantitative clinical features and response to cholestyramine
1998
A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones
1993 Standout
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
2001 Standout
Diet rapidly and reproducibly alters the human gut microbiome
2013 StandoutNature
A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.
1998
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
1999
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11
2003
A multicenter, randomized, controlled clinical trial of interferon alfacon-1 in comparison with lymphoblastoid interferon-alpha in patients with high-titer chronic hepatitis C virus infection
2002
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria
2002 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
2006
An increasing number of calcium oxalate stone events worsens treatment outcome
1994
Protein therapeutics: a summary and pharmacological classification
2007 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Antibiotic-Associated Diarrhea
2002 Standout
Hepatobiliary transport
2000
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Irritable Bowel Syndrome
2015 Standout
Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias
1978
Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women
2010
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms
2009 StandoutNobel
Prospective Comparison of Indirect Methods for Detecting Lactase Deficiency
1975
Hyperoxaluria in Patients with Ileal Resection: An Abnormality in Dietary Oxalate Absorption
1974
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium.
1984
Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests
1978 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Racial differences in responses to therapy with interferon in chronic hepatitis C
1999
Reverse-phase h.p.l.c. separation, quantification and preparation of bilirubin and its conjugates from native bile. Quantitative analysis of the intact tetrapyrroles based on h.p.l.c. of their ethyl anthranilate azo derivatives
1985
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Lipopolysaccharide Endotoxins
2002 Standout
Directed Evolution ofVibrio fischeriLuxR for Improved Response to Butanoyl-Homoserine Lactone
2007 StandoutNobel
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
A Further Study of Oxalate Bioavailability in Foods
1990
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Works of Hans Fromm being referenced
Comparative binding of bile acids to serum lipoproteins and albumin
1993
pH-dependent uptake of irinotecan and its active metabolite, SN-38, by intestinal cells
1999
Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial
1997
Multiple malignant gastric stromal tumors presenting with GI bleeding: a case report and a review of the literature
2000
Extrahepatic deposition and cytotoxicity of lithocholic acid: Studies in two hamster models of hepatic failure and in cultured human fibroblasts
1998
Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection
1998
Biochemical and Viral Response to Consensus Interferon (Cifn) Therapy in Chronic Hepatitis C Patients: Effect of Baseline Viral Concentration
1999
Signal transduction and hepatocellular bile acid transport: Cross talk between bile acids and second messengers
1999
Sensitivity and Specificity in Tests of Distal Ileal Function: Prospective Comparison of Bile Acid and Vitamin B12 Absorption in Ileal Resection Patients
1973
Tests of Bile-acid and Vitamin B12Metabolism in Ileal Crohn’s Disease
1980
Absence of significant role of bile acids in diarrhea of a heterogeneous group of postcholecystectomy patients
1987
Gallstone dissolution therapy
1986
Ursodeoxycholate mobilizes intracellular Ca2+ and activates phosphorylase a in isolated hepatocytes
1993
Bile Acid-Induced Diarrhoea
1986
Breath test for altered bile-acid metabolism
1971
Acquired hyperoxaluria and intestinal disease. Evidence that bile acid glycine is not a precursor of oxalate.
1973
Acquired Hyperoxaluria, Nephrolithiasis, and Intestinal Disease
1972
Comparative Efficacy and Side Effects of Ursodeoxycholic and Chenodeoxycholic Acids in Dissolving Gallstones
1983
Modulation of low density lipoprotein receptor activity by bile acids: differential effects of chenodeoxycholic and ursodeoxycholic acids in the hamster
1987
Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC
1995
Sensitivity and specificity in tests of distal ileal function: prospective comparison of bile acid and vitamin B 12 absorption in ileal resection patients.
1973
Alteration of cAMP-mediated hormonal responsiveness by bile acids in cells of nonhepatic origin
1995
Factors in the mechanism of diarrhea in bile acid malabsorption: Fecal pH—A key determinant
1981
Use of a simple enzymatic assay for cholesterol analysis in human bile.
1980
New treatment for primary sclerosing cholangitis: Promising results with ursodiol
1992